FDA Inspection 1089541 — The Ritedose Corporation

The Ritedose Corporation — FEI 3001237796

The FDA completed an inspection of The Ritedose Corporation on Apr 18, 2019 in Columbia, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 18, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Columbia, SC (United States)

Additional details

Bioanalytical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.